AI drug researcher XtalPi lists in Hong Kong amid U.S.-China rivalry

Exchange pins high hopes on first IPO under rule designed to woo innovative startups

20240613 XtalPi listing ceremony.JPG

QuantumPharm, a Chinese AI-driven drug research company known as XtalPi and backed by Tencent, lists in Hong Kong on June 13. (Photo by Peggy Ye)

PEGGY YE, Nikkei staff writer

HONG KONG -- QuantumPharm, a Chinese AI-driven drug research company known as XtalPi and backed by Tencent, began trading in Hong Kong on Thursday.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.